X-150770368-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_031462.4(CD99L2):ā€‹c.657G>Cā€‹(p.Gln219His) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,209,335 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000053 ( 0 hom., 1 hem., cov: 24)
Exomes š‘“: 0.000015 ( 0 hom. 3 hem. )

Consequence

CD99L2
NM_031462.4 missense, splice_region

Scores

4
8
Splicing: ADA: 0.0001546
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.659
Variant links:
Genes affected
CD99L2 (HGNC:18237): (CD99 molecule like 2) This gene encodes a cell-surface protein that is similar to CD99. A similar protein in mouse functions as an adhesion molecule during leukocyte extravasation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.103094816).
BS2
High Hemizygotes in GnomAdExome4 at 3 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CD99L2NM_031462.4 linkuse as main transcriptc.657G>C p.Gln219His missense_variant, splice_region_variant 10/11 ENST00000370377.8 NP_113650.2 Q8TCZ2-1A0A024RC16

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CD99L2ENST00000370377.8 linkuse as main transcriptc.657G>C p.Gln219His missense_variant, splice_region_variant 10/111 NM_031462.4 ENSP00000359403.3 Q8TCZ2-1

Frequencies

GnomAD3 genomes
AF:
0.0000535
AC:
6
AN:
112184
Hom.:
0
Cov.:
24
AF XY:
0.0000291
AC XY:
1
AN XY:
34370
show subpopulations
Gnomad AFR
AF:
0.0000973
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000187
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000492
AC:
9
AN:
183072
Hom.:
0
AF XY:
0.0000444
AC XY:
3
AN XY:
67548
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.0000730
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000245
Gnomad OTH exome
AF:
0.000664
GnomAD4 exome
AF:
0.0000146
AC:
16
AN:
1097151
Hom.:
0
Cov.:
29
AF XY:
0.00000828
AC XY:
3
AN XY:
362519
show subpopulations
Gnomad4 AFR exome
AF:
0.000114
Gnomad4 AMR exome
AF:
0.000114
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000713
Gnomad4 OTH exome
AF:
0.0000651
GnomAD4 genome
AF:
0.0000535
AC:
6
AN:
112184
Hom.:
0
Cov.:
24
AF XY:
0.0000291
AC XY:
1
AN XY:
34370
show subpopulations
Gnomad4 AFR
AF:
0.0000973
Gnomad4 AMR
AF:
0.000187
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000741
AC:
9
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 10, 2024The c.687G>C (p.E229D) alteration is located in exon 11 (coding exon 11) of the CD99L2 gene. This alteration results from a G to C substitution at nucleotide position 687, causing the glutamic acid (E) at amino acid position 229 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
13
DANN
Benign
0.97
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.39
T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.10
T
MetaSVM
Benign
-1.1
T
PrimateAI
Uncertain
0.50
T
Sift4G
Uncertain
0.025
D
Vest4
0.34
MVP
0.79
ClinPred
0.038
T
GERP RS
2.3
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00015
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs369555905; hg19: chrX-149938841; API